We are live on ! Find out more
PYXS icon

Pyxis Oncology
PYXS

51 hedge funds and large institutions have $200M invested in Pyxis Oncology in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55.98% more ownership

Funds ownership: 0% → 55.98% (+56%)

Holders
51
Holders Change
+51
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
51
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$26.1M
2
RI
RTW Investments
New York
+$24.3M
3
PA
Perceptive Advisors
New York
+$22.3M
4
BI
BVF Inc
California
+$20.5M
5
Citadel Advisors
Citadel Advisors
Florida
+$17.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$25M +$26.1M +2,282,173 New
RI
2
RTW Investments
New York
$23.3M +$24.3M +2,120,760 New
PA
3
Perceptive Advisors
New York
$21.3M +$22.3M +1,944,114 New
BI
4
BVF Inc
California
$19.7M +$20.5M +1,791,351 New
Citadel Advisors
5
Citadel Advisors
Florida
$16.5M +$17.4M +1,521,617 New
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$15.3M +$16.8M +1,469,091 New
LCM
7
Laurion Capital Management
New York
$12.8M +$13.3M +1,162,332 New
HA
8
HHLR Advisors
Cayman Islands
$8.39M +$8.75M +764,406 New
ACP
9
Acuta Capital Partners
California
$7.43M +$7.76M +677,753 New
CAM
10
Cormorant Asset Management
Massachusetts
$7.12M +$7.66M +668,854 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$5.71M +$5.96M +520,298 New
BlackRock
12
BlackRock
New York
$5.64M +$5.88M +513,848 New
GPP
13
Great Point Partners
Connecticut
$4.39M +$4.58M +400,000 New
DM
14
Deerfield Management
New York
$3.42M +$3.57M +311,754 New
GTC
15
Ghost Tree Capital
New York
$3.24M +$3.38M +295,000 New
LGM
16
Logos Global Management
California
$3.14M +$3.28M +286,652 New
ECM
17
ExodusPoint Capital Management
New York
$2.74M +$2.86M +249,762 New
HM
18
HealthCor Management
New York
$2.69M +$2.8M +244,838 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.99M +$2.08M +181,472 New
O
20
OrbiMed
New York
$1.58M +$1.64M +143,640 New
TCM
21
Tekla Capital Management
Massachusetts
$1.48M +$1.55M +135,000 New
PVI
22
Pura Vida Investments
New York
$1.24M +$1.29M +112,762 New
State Street
23
State Street
Massachusetts
$1.02M +$1.06M +92,875 New
Northern Trust
24
Northern Trust
Illinois
$979K +$1.02M +89,235 New
CCM
25
CAAS Capital Management
New York
$549K +$572K +50,000 New
1
2 3

PYXS Hedge Fund Activity: Q4 2021 in Review

51 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q4 2021, worth a combined $200M.

Buyers outnumbered sellers: 51 funds opened new PYXS positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $26.1M.

  • 51 institutional investors held Pyxis Oncology (PYXS) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $200M of Pyxis Oncology stock for Q4 2021.
  • 51 funds opened new Pyxis Oncology positions in Q4 2021 and 0 closed out, a net change of +51 holders.
  • The largest Pyxis Oncology buyer in Q4 2021 was RA Capital Management, an estimated $26.1M added.

Based on aggregated 13F filings for Q4 2021.